Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
- 17 October 2018
- journal article
- review article
- Published by Elsevier BV in Metabolism
- Vol. 90, 1-15
- https://doi.org/10.1016/j.metabol.2018.10.005
Abstract
No abstract availableKeywords
This publication has 184 references indexed in Scilit:
- Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trialBMC Medicine, 2013
- Comparison of Explant-Derived and Enzymatic Digestion-Derived MSCs and the Growth Factors from Wharton’s JellyBioMed Research International, 2013
- New lessons learned from disease modeling with induced pluripotent stem cellsCurrent Opinion in Genetics & Development, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL-37The International Journal of Cell Cloning, 2010
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?The International Journal of Cell Cloning, 2010
- Mesenchymal and haematopoietic stem cells form a unique bone marrow nicheNature, 2010
- Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming ProteinsCell Stem Cell, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006